The Genome Institute of Singapore (GIS) is pivotal in advancing genomic sciences and biomedical research.
Given its critical contributions to healthcare, biotechnology, and public health, GIS must maintain operational resilience to ensure the continuity of its essential business functions.
This chapter explores the key business functions of GIS that must be safeguarded through a robust Business Continuity Management (BCM) framework.
As a leading research institute, GIS conducts cutting-edge genomic studies that advance precision medicine, disease prevention, and treatment strategies.
Disruptions to research activities—whether due to cyberattacks, equipment failure, or pandemics—can delay scientific breakthroughs and affect collaborations with global partners.
The institute relies heavily on computational biology and bioinformatics to interpret genomic data. The loss of computational resources due to IT failures, cyber incidents, or power outages could severely impact research timelines.
GIS collaborates with hospitals, pharmaceutical companies, and regulatory agencies to translate genomic research into clinical applications. Disruptions can hinder patient-centric studies, regulatory approvals, and clinical trials.
GIS laboratories handle biological samples, reagents, and other sensitive materials that require precise environmental conditions. Any disruption could lead to sample degradation and compromise research integrity.
The institute depends on government grants, philanthropic contributions, and industry funding to sustain its operations. Disruptions in financial processes could delay funding disbursements, affecting ongoing projects.
GIS works closely with international research institutions, healthcare organizations, and government agencies.
Effective communication and stakeholder coordination are critical to maintaining research partnerships and institutional credibility during crises.
The expertise of GIS’s scientists, researchers, and administrative personnel is indispensable to its operations. Workforce disruptions due to health crises, attrition, or unforeseen events can impact productivity and research output.
To sustain its mission and scientific contributions, the Genome Institute of Singapore must ensure its critical business functions remain resilient against disruptions.
A comprehensive BCM strategy will help safeguard GIS’s research, data, operations, and stakeholder relationships, ensuring long-term stability and innovation in genomic sciences.
|
If you have any questions, click to contact us.
|
||